Pathological hypersexuality induced by dopamine replacement therapy in a patient with progressive supranuclear palsy

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 20, Issue 4, 2008, Pages 496-497

  Kim, Yang Yeol ^a   Park, Hye Yoon ^a   Kim, Jong Min ^a   Kim, Ki Woong ^b  

^a Department of Neuropsychiatry ^*

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; PRAMIPEXOLE; PROLACTIN; TESTOSTERONE;

ADD ON THERAPY; AGED; CASE REPORT; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXHIBITIONISM; FLUSHING; HUMAN; HYPERSEXUALITY; LETTER; MALE; MASTURBATION; MOTOR PERFORMANCE; NAUSEA; OPTIMAL DRUG DOSE; PENIS ERECTION; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROLACTIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; TOUCH; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 61849184415     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2008.20.4.496     Document Type: Letter

References (3)

1. Klos KJ, Bower JH, Josephs KA, et al: Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord 2005; 11:381-386
2. Foley P, Gerlach M, Double KL, et al: Dopamine receptor agonists in the therapy of Parkinson's disease. J Neural Transm 2004; 111:1375-1446
3. Uitti RJ, Tanner CM, Rajput AH, et al: Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 1989; 12:375-383